Hostname: page-component-78c5997874-lj6df Total loading time: 0 Render date: 2024-11-05T12:43:58.312Z Has data issue: false hasContentIssue false
  • English
  • Français

Towards control of schistosomiasis in sub-Saharan Africa

Published online by Cambridge University Press:  12 April 2024

V.R. Southgate ,
D. Rollinson ,
L.A. Tchuem Tchuenté  and
P. Hagan
V.R. Southgate*
Affiliation:
Parasitology Division, Wolfson Wellcome Biomedical Laboratories, Department of Zoology, The Natural History Museum, South Kensington, London, SW7 5BD, UK
D. Rollinson
Affiliation:
Parasitology Division, Wolfson Wellcome Biomedical Laboratories, Department of Zoology, The Natural History Museum, South Kensington, London, SW7 5BD, UK
L.A. Tchuem Tchuenté
Affiliation:
National Programme for Control of Schistosomiasis and Soil Transmitted Helminths, Centre of Schistosomiasis and Parasitology, PO Box 7244, Yaoundé, Cameroon
P. Hagan
Affiliation:
Division of Infection and Immunity, IBLS Joseph Black Building, University of Glasgow, Glasgow, G12 8QQ, UK
*
*Author for correspondence Fax: 0044 207942 5518 E-mail: [email protected]
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Approximately 80% of the 200 million people infected with schistosomiasis inhabit sub-Saharan Africa, and the annual mortality is estimated to be 280,000. Praziquantel is the drug of choice in the treatment of schistosomiasis and pregnant women may now be treated. It was agreed at the World Health Assembly in 2001 that at least 75% of school-aged children in high burden areas should be treated for schistosomiasis and soil-transmitted helminth infections by 2010 to reduce morbidity. A grant from the Bill and Melinda Gates Foundation to the Schistosomiasis Control Initiative, Imperial College of Science, Technology and Medicine, London has enabled control programmes to be initiated in Uganda, Tanzania, Zambia, Burkina Faso, Niger and Mali. Additional programmes have recently commenced in Zanzibar with a grant from the Health Foundation to The Natural History Museum, London and in Cameroon. Combination treatment for schistosomiasis, gastrointestinal helminths and filariasis reduces costs of control programmes. The EC Concerted Action Group on ‘Praziquantel: its central role in the chemotherapy of schistosome infection’ met in Yaoundé Cameroon in 2004 to discuss recent developments in laboratory and field studies. The use of standard operating procedures will enable data on drug action on schistosomes produced in different laboratories to be compared. With the ever increasing use of praziquantel there is a possibility of the development of resistance by schistosomes to the drug, hence the necessity to explore the activities of other compounds. Artemether, unlike praziquantel, is effective against immature schistosomes. The effectiveness of mirazid, an extract of myrrh, is controversial as data from different laboratories are equivocal. It is suggested that an independent body such as the World Health Organization should determine whether mirazid should be used in the treatment of schistosomiasis.

Type
Review Article
Information
Journal of Helminthology , Volume 79 , Issue 3 , September 2005 , pp. 181 - 185
Copyright
Copyright © Cambridge University Press 2005

References

Adam, I. Elwasila, E.T. & Homeida, M. (2004) Is praziquantel therapy safe during pregnancy?. Transactions of the Royal Society of Tropical Medicine and Hygiene 98, 540–543.CrossRefGoogle ScholarPubMed
Albonico, M. Wright, V. & Bickle, Q. (2004) Molecular analysis of the ß-tubulin gene of human hookworms as a basis for possible benzimidazole resistance on Pemba Island. Molecular and Biochemical Parasitology 134, 281–284.CrossRefGoogle Scholar
Botros, S. Sayed, H. El-Dusoki, H. Sabry, H. Rabie, I. El-Gjhannam, M. Hassanein, M. Abd-Waham, Y. & Engels, D. (2005) Efficacy of mirazid in comparison with praziquantel in Egyptian Schistosoma mansoni -infected school children and households. American Journal of Tropical Medicine and Hygiene 72, 119–123.CrossRefGoogle ScholarPubMed
Cioli, D. & Pica-Mattoccia, L. (2003) Praziquantel. Parasitology Research 90 S3–S9.CrossRefGoogle ScholarPubMed
Crompton, D.W.T. & Neisheim, M.C. (2002) Nutritional impact of intestinal helminthiasis during the human life cycle. Annual Review of Nutrition 22, 35–59.CrossRefGoogle ScholarPubMed
Engels, D. Chitsulo, L. Montresor, A. & Savioli, L. (2002) The global status of schistosomiasis and its control. Acta Tropica 82, 139–146.CrossRefGoogle Scholar
Kabatereine, N.B. Tukahebwa, E., Kazibwe, F., Namwangye, H., Zaramba, S., Brooker, S., Stothard, J.R., Kamenka, C., Whawell, J., Webster, J. & Fenwick, A. ((2005)) Fresh fromthe field; country wide control of schistosomiasis and soil transmitted helminthiasis (STH) in Uganda. Transactions of the Royal Society of Tropical Medicine and Hygiene (in press).Google Scholar
King, C.H. Dickman, K. & Tisch, D.J. (2003) Re-gauging the cost of schistosomiasis: a meta-analysis of disability-related outcomes in endemic populations. American Journal of Tropical Medicine and Hygiene 69, 513–514.Google Scholar
King, C.H. Dickman, K. & Tisch, D.J. (2005) Reassessment of the cost of chronic helmintic infection: a meta-analysis of disability-related outcomes in endemic schistosomiasis. Lancet 365, 1561–1569.CrossRefGoogle ScholarPubMed
Laamrani, H. Mahjour, J. Madsen, H. Khallaayoune, K. & Gryseels, B. (2000) Schistosoma haematobium in Morocco; moving from control to elimination. Parasitology Today 16, 257–260.CrossRefGoogle ScholarPubMed
Report for the Commission of Africa (2005) www.commisionforafrica.org.Google Scholar
Schistosomiasis Control Initiative (2004) Mid term review 20pp. London, Imperial College.Google Scholar
Sheir, Z. Amira, A.N. Massoud, A. Salama, O. Badra, G.A. El-Shennaw, H. Hassan, N. & Hammad, S.M. (2001) A safe, effective, herbal antischistosomal therapy derived from myrrh. American Journal of Tropical Medicine and Hygiene 65, 700–704.CrossRefGoogle ScholarPubMed
Southgate, V.R. (1997) Schistosomiasis in the Senegal River Basin: before and after construction of the dams at Diama, Senegal and Manantali, Mali and future prospects. Journal of Helminthology 71, 125–132.CrossRefGoogle ScholarPubMed
Tchuem Tchuenté, L.A, Behnke, J.M. Gibert, F.S. Southgate, V.R. & Vercruysse, J. (2003) Polyparasitism with Schistosoma haematobium and soil-transmitted helminth infections among school children in Loum, Cameroon. Tropical Medicine and International Health 8, 975–986.CrossRefGoogle ScholarPubMed
Utzinger, J. Chollet, J. Jiqing, Y. Jinyan, M. Tanner, M. & Shuhua, X. (2001) Effect of combined treatment with praziquantel and artemether on Schistosoma japonicum and Schistosoma mansoni in experimentally infected animals. Acta Tropica 80, 9–18.CrossRefGoogle ScholarPubMed
Utzinger, J. Bergquist, R. Shu-Hua, X. Singer, B.H. & Tanner, M. (2003) Sustainable schistosomiasis control–the way forward. Lancet 362, 1932–1933.CrossRefGoogle ScholarPubMed
van der Werf, M.J. de Vlass, S.J. Brooker, S. Looman, C.W.N. Nagelkerke, N.J.D. Habbema, J.D.F. & Engels, D. (2003) Quantification of clinical morbidity associated with schistosome infection in sub-saharan Africa. Acta Tropica 86, 125–139.CrossRefGoogle ScholarPubMed
WHO (2001) Schistosomiasis and soil transmitted helminth infections. Fifty fourth World Health Assembly, resolution WHA54.19. www.http://who.int/gb/EB_WHA/PDF/WHA54r19.pdf.Google Scholar
WHO (2002) Prevention and control of schistosomiasis and soil-transmitted helminthiasis; report of a WHO Expert Committee. WHO Technical Report Series No.912 Geneva, World Health Organization.Google Scholar